
Fentanyl-Removal Drug CS-1103 Meets All Endpoints in Phase 2 Trial
Clear Scientific's CS-1103, a first-in-class sequestrant, accelerated fentanyl clearance into urine 25-fold in a 16-person Phase 2 trial. Phase 3 is set for 2027.
Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.

Clear Scientific's CS-1103, a first-in-class sequestrant, accelerated fentanyl clearance into urine 25-fold in a 16-person Phase 2 trial. Phase 3 is set for 2027.

Proposition 132 would make possessing any amount of fentanyl a felony with mandatory prison time and sharply raise penalties for selling it, at a cost of millions.

HHS selected eight communities, from Huntington, West Virginia, to the Cherokee Nation, to share $96 million over four years for street-based addiction and homelessness care.

Spending reports released Thursday show New Jersey towns used opioid settlement money on concerts, bounce houses and a muscle car, prompting an oversight bill.

A federal complaint accuses an Oxford, Mississippi, vape shop clerk and his son of selling a kratom product tied to the death of Ole Miss student Aidan Hamilton.

A JAMA Network Open analysis of 229,847 young Medicaid enrollees finds only half start opioid addiction treatment and just 3.1% stay on medication past 180 days.
SAMHSA resumed the 988 Suicide and Crisis Lifeline's Press 3 option for LGBTQ+ youth on Sept. 30, ending a 14-month gap that began when the Trump administration cut it.

Gov. Matt Meyer signed Senate Bill 249 and Executive Order 28, creating a licensing framework for harm-reduction programs and decriminalizing paraphernalia.

A federal class action filed in Boston alleges DraftKings used machine learning to single out gamblers likely to lose more and then target them with promotions.